ArticleNeuro-oncology2025

EVA1-antibody drug conjugate is a new therapeutic strategy for eliminating glioblastoma-initiating cells.

Jiahui Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.